Standout Papers

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. 1997 2026 2006 2016 523
  1. Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. (1997)
    W ten Bokkel Huinink, Martin Gore et al. Journal of Clinical Oncology
  2. A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery (2005)
    Giancarlo Agnelli, Giorgio Bolis et al. Annals of Surgery

Immediate Impact

14 by Nobel laureates 8 from Science/Nature 59 standout
Sub-graph 1 of 16

Citing Papers

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
1 intermediate paper

Works of Giorgio Bolis being referenced

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.
1997 Standout
Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors
1980

Author Peers

Author Last Decade Papers Cites
Giorgio Bolis 3017 1054 1493 1746 1652 144 6.0k
Steven J. Skates 3515 2133 1278 1066 1196 124 8.4k
Sean Kehoe 2854 686 2201 1771 1302 143 5.5k
J. Michael Straughn 1341 1002 1208 773 1225 188 4.3k
Sigurd Lax 1133 1462 1586 621 2083 143 5.8k
W. Lichtenegger 1554 992 1121 964 1777 243 4.5k
William A. Cliby 6568 3657 5042 4012 3376 281 13.8k
Walther Kuhn 1449 929 811 946 1635 118 5.5k
Claire F. Verschraegen 1158 1920 672 1042 2909 264 6.7k
Gordon Rustin 5054 3993 1235 3348 5247 244 15.7k
S. Diane Yamada 1805 3014 1702 1314 2157 100 7.8k

All Works

Loading papers...

Rankless by CCL
2026